Beleave Inc. announced that it has secured genetics acquisition agreements for a broad range of cannabis seed varieties from diverse lineages. There will be a total of 90 new varieties introduced in the coming year that have been selected to cover the entire spectrum of low, intermediate, and high THC and CBD profiles. The list includes well-known classic Sativa and Indica varieties with applications for both medical and adult recreational markets. Also included in the selection are a number of novel strains, not previously available in the Canadian market, which have been bred for select terpene profiles to offer distinct custom flavours and aromas. In the coming months, the company will be completing construction and upgrades on new facilities in Ontario and British Columbia. Once completed, they will greatly increase the Company's production capacity allowing Beleave to help supply the demands of Canada's growing cannabis market.